PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

June 22, 2025 updated by: Brian Declan O'Donnell, University College Cork

A Double Blind Randomised Controlled Trial Comparing Continuous Infusion vs. Programmed Intermittent Bolus Via a Pericapsular Nerve Group (PENG) Catheter for Post Operative Fractured Neck of Femur Analgesia

Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery. It is unclear from the published literature whether an optimal strategy of local anaesthetic delivery has been characterized.

Similar doses of local anaesthetic agents can be administered by either continuous infusion or timed intermittent bolus. It is unclear whether one dosing strategy is superior to the other in the context of hip fracture analgesia. The study aims to evaluate the clinical efficacy of both dosing strategies in patients undergoing hip fracture surgery.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The latest Irish Hip Fracture Database (IHFD) National Report published in 2020 counted 3,666 hip fractures in patients aged over 60 during the year 2020 across the Republic of Ireland. Ninety five percent of these patients received surgical fixation representing a significant clinical workload. Hip fractures are most often associated with increasing age and frailty and indeed 52% of patients included in the IHFD report were aged over 80 years. Fractures of the proximal femur are painful and, in the absence of regional analgesia, usually require strong opioids to control. Patients of this age group are more likely to suffer from cognitive impairment (31% in the IHFD cohort) and reduced renal function, both of which complicate opioid use making their avoidance desirable. Impaired renal function and ischaemic heart disease, which is also common in this cohort, also contraindicate non-steroidal anti-inflammatory drug (NSAID) use. Such limitations make analgesia challenging following hip fracture surgery and it is known that poor perioperative analgesia in this group increases the incidence of delirium, a factor independently associated with increased requirement for long term care and mortality. It is essential therefore that effective peri-operative analgesia is prioritised and provided in such a way that minimises potential cognitive, renal and cardiovascular complications. Regional analgesia provides a simple and effective way to ensure high-quality pain relief throughout the acute hip fracture journey whilst avoiding many of the complications associated with the use of systemic analgesia. Pre-operative ultrasound guided regional analgesia has now become the standard of care for patients presenting to the emergency department with fractured neck of femur. The recent procedure specific post operative pain management (PROSPECT) recommendations from the PROSPECT group and the European Society of Regional Anaesthesia and Pain Medicine (ESRA) regarding hip fracture repair surgery recommend either a single short femoral nerve block (FNB) or a fascia iliaca compartment block (FICB) due to their pain score lowering and opioid sparing effects2. They go on to say that there is currently insufficient evidence to recommend peri-capsular nerve group (PENG) blocks or the routine use of catheter-based techniques citing the potential for prolonged motor block being an additional concern for the latter. As such the PENG block and cathether-based techniques need to be studied in more detail to allow national and international guidance groups to make appropriate recommendations.

The nerve supply to the hip joint and surrounding structures is primarily via the femoral, obturator and accessory obturator nerves (L2 - L4) anteriorly and the sciatic nerve (L4 - S3) posteriorly. The superior and inferior gluteal nerves and the quadratus femoris nerve, branches of the sacral plexus, also contribute to the posterior innervation of the hip joint. The PENG block has been relatively recently described as a technique for analgesia following hip surgery as an alternative to more traditional regional analgesia techniques such as the FNB or FICB3. It involves placing local anaesthetic beneath the psoas tendon in the iliopsoas groove of the ilium and pubis bones between the anterior inferior iliac spine and the medial border of the iliopubic eminence. The aim of the block is to anaesthetise the articular branches of the obturator, accessory obturator and femoral nerves supplying the anterior capsule of the hip which run over or close to this groove and into the hip capsule3. These nerves are small and not easily visible on ultrasound and as such the end point of the block is local anaesthetic spread along the periosteal groove; for this reason the PENG block could be considered a fascial plane block. There is considerable anatomical variation between individuals in the number, origin, course and sensory supply of the articular branches of these nerves4, it is important therefore that relatively large volumes of local anaesthetic are used to ensure sufficient spread from the point of injection to reach the target nerves, indeed in the original description of the block the volume used was 20ml3. The PENG block theoretically has advantages over the FNB and FICB in that it only targets the articular branches and not the primary nerves and thus potentially has less effect on quadriceps power5,6. This has important implications for the early mobilisation and physiotherapy engagement post-operatively.

At our institution the current analgesic pathway for patients undergoing hemiarthroplasty surgery for fractured neck of femur includes a PENG block immediately before surgery. In almost all cases the patient also simultaneously receives a PENG catheter which is used into the post-operative period for ongoing regional analgesia. The infusion usually runs for approximately 48 - 72 hours with the patients being followed up daily by an acute pain team. All patients presenting to the hospital with fractured neck of femur also receive a single shot block, either a FNB or a FICB in the emergency department. This typically happens between 12 and 48 hours pre-operatively.

Programmed intermittent bolus (PIB) protocols involve the delivery of a set volume of local anaesthetic via a pump at a set time interval delivered as a bolus rather than a continuous infusion. There is strong evidence in the obstetric population for the benefits of programmed intermittent bolus (PIB) for labour epidural analgesia especially when combined with a patient controlled epidural analgesia (PCEA) element. Improved maternal satisfaction with analgesia as well as an overall reduction in total local anaesthetic infused are amongst the benefits which have led to many obstetric units switching over to the technique7 The evidence for PIB infusion techniques via peripheral nerve catheters is less well established however improved pain scores at 24 and 48 hours post operatively as well as improved patient satisfaction and decreased requirement for rescue analgesia have been reported8. The results are however conflicting, this is exacerbated by the wide gamut of different peripheral nerve blocks each with their own anatomical characteristics. It would seem logical that plane blocks, such as the PENG block, would benefit more from a PIB protocol given the importance of local anaesthetic spread in these techniques but this has also not been consistently shown7. There are promising results from studies of PIB vs. CI in thoracic paravertebral catheters (a block which similarly requires larger volumes of local anaesthetic for improved spread) for thoracic surgery9,10.

Previous literature reviews of intermittent bolus versus continuous infusions techniques have highlighted the paucity of evidence in this area and the heterogenicity of the patients and techniques in the few trials that are available7. Hip fracture represents an ideal index condition for studying this topic given the large numbers of patients and the frequent use of peripheral nerve catheters in this population. PENG catheters, being a relatively new technique, need to be assessed using a PIB protocol to establish its effectiveness in comparison to more traditional CI protocols. It is hoped that in conducting this trial we will be able to assess the efficacy of PIB techniques in PENG catheters used for analgesia following femoral hemiarthroplasty after fractured neck of femur.

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Brian D O'Donnell, MBBChBAO MSc FCARCSI MD
  • Phone Number: +353872780225
  • Email: briodnl@gmail.com

Study Locations

  • Ireland
      • Cork, Ireland, P85 FR62
        • Recruiting
        • Cork University Hospital
        • Contact:
          • Brian D O'Donnell, MBBChBAO MSc FCARCSI MD
          • Phone Number: +353872780225
          • Email: briodnl@gmail.com
        • Sub-Investigator:
          • Benjamin P Atterton, MBChB FRCA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • English-speaking
  • over the age of 18 years
  • hemiarthroplasty for fractured neck of femur
  • able to provide written consent.

Exclusion Criteria:

  • under 50kg body weight.
  • unable to provide consent due to incapacity
  • pregnant women
  • vulnerable adults under state guardianship
  • Patients with pre-existing chronic pain disorders or with a history of long-term opioid use
  • those with contraindications to a peripheral nerve block such as local site infection, allergy to local anaesthetic or those who are coagulopathic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Continuous PENG Infusion
Participants will be randomly assigned to this arm and will receive a continuous infusion of levobupivacaine.
Other: continuous infusion of levobupivacaine
Participants in this arm will receive a continuous infusion of levobupivacaine via a regional anaesthesia catheter placed in the PENG fascial space. The total dose over 24 hours will be equivalent in both arms of the study.
Experimental: Programmed Intermittent Bolus PENG
Participants will be randomly assigned to this arm and will receive a timed pre-set bolus dose of levobupivacaine.
Other: Programmed Intermittent Bolus of Levobupivacaine
Participants in this arm will receive a timed pre-set bolus dose of levobupivacaine via a regional anaesthesia catheter placed in the PENG fascial space. The total dose over 24 hours will be equivalent in both groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Rating Pain Scale (NRS 0-10)
Time Frame: 48 Hours Post-operatively
Patients will be invited to rate their post operative pain at rest and on movement on a 0-10 scale; where 0 is no pain and 10 is worst imaginable pain.
48 Hours Post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Rating Pain Scale (NRS 0-10)
Time Frame: 1, 2, 4, 24 hours postoperatively
1, 2, 4, 24 hours postoperatively
Quality of Recovery 15 (QOR15)
Time Frame: 48 hours postoperatively
Patients will be invited to complete a validated multidomain assessment of recovery following anaesthesia and surgery.
48 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University College Cork

Investigators

  • Study Director: Benjamin P Atterton, MBChB FRCA, Cork University Hospital & University College Cork

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2024

Primary Completion (Estimated)

January 7, 2026

Study Completion (Estimated)

January 7, 2026

Study Registration Dates

First Submitted

June 22, 2025

First Submitted That Met QC Criteria

June 22, 2025

First Posted (Estimated)

July 1, 2025

Study Record Updates

Last Update Posted (Estimated)

July 1, 2025

Last Update Submitted That Met QC Criteria

June 22, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PIB PENG RCT ECM5(3)5/3/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We have not considered making IPD available but would consider doing so with appropriate data security safeguards in place with collaborators on request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fracture

Clinical Trials on continuous infusion of levobupivacaine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe